nach oben

World Journal of Urology

Erschienen in:

01.06.2014 | Topic Paper

The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation

verfasst von: Tobias Klatte, Nils Kroeger, Uwe Zimmermann, Martin Burchardt, Arie S. Belldegrun, Allan J. Pantuck

Erschienen in: World Journal of Urology | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Currently, most of renal tumors are small, low grade, with a slow growth rate, a low metastatic potential, and with up to 30 % of these tumors being benign on the final pathology. Moreover, they are often diagnosed in elderly patients with preexisting medical comorbidities in whom the underlying medical conditions may pose a greater risk of death than the small renal mass. Concerns regarding overdiagnosis and overtreatment of patients with indolent small renal tumors have led to an increasing interest in minimally invasive, ablative as an alternative to extirpative interventions for selected patients.

Objective

To provide an overview about the state of the art in radiofrequency ablation (RFA), high-intensity focused ultrasound, and cryoablation in the clinical management of renal cell carcinoma.

Methods

A PubMed wide the literature search of was conducted.

Results

International consensus panels recommend ablative techniques in patients who are unfit for surgery, who are not considered candidates for or elect against elective surveillance, and who have small renal masses. The most often used techniques are cryoablation and RFA. These ablative techniques offer potentially curative outcomes while conferring several advantages over extirpative surgery, including improved patient procedural tolerance, faster recovery, preservation of renal function, and reduction in the risk of intraoperative and postsurgical complications. While it is likely that outcomes associated with ablative modalities will improve with further advances in technology, their application will expand to more elective indications as longer-term efficacy data become available.

Conclusion

Ablative techniques pose a valid treatment option in selected patients.

Birkhäuser F, Kroeger N, Pantuck A (2012) Etiology of RCC: incidence, demographics, and environmental factors. In: Rini B, Campbell S (eds) Renal cell carcinoma: clinical management, vol 1. Springer Science +Business Media, New York, pp 3–22

Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA (2010) Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 116:3135–3142PubMedCrossRef

Van Poppel H, Becker F, Cadeddu JA, Gill IS, Janetschek G, Jewett MA, Laguna MP, Marberger M, Montorsi F, Polascik TJ, Ukimura O, Zhu G (2011) Treatment of localised renal cell carcinoma. Eur Urol 60:662–672PubMedCrossRef

Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, Chen DY, Jewett MA, Greenberg RE, Uzzo RG (2012) Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 118:997–1006PubMedCrossRef

Whitson JM, Harris CR, Meng MV (2012) Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses. BJU Int 110:1438–1443 (discussion 1443)

Kowalczyk KJ, Choueiri TK, Hevelone ND, Trinh QD, Lipsitz SR, Nguyen PL, Lynch JH, Hu JC (2013) Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007. BJU Int 112:E273–E280PubMedCrossRef

Castle SM, Gorbatiy V, Avallone MA, Eldefrawy A, Caulton DE, Leveillee RJ (2013) Cost comparison of nephron-sparing treatments for cT1a renal masses. Urol Oncol 31:1327–1332PubMedCrossRef

Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF, Sinescu IC (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406PubMedCrossRef

Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63:486–492PubMedCrossRef

10.

Vogl TJ, Muller PK, Mack MG, Straub R, Engelmann K, Neuhaus P (1999) Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol 9:675–684PubMedCrossRef

11.

Rossi S, Buscarini E, Garbagnati F, Di Stasi M, Quaretti P, Rago M, Zangrandi A, Andreola S, Silverman D, Buscarini L (1998) Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 170:1015–1022PubMedCrossRef

12.

Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L, Paties CT, Silverman DE, Buscarini L (1996) Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 167:759–768PubMedCrossRef

13.

Hiraki T, Gobara H, Iishi T, Sano Y, Iguchi T, Fujiwara H, Tajiri N, Sakurai J, Date H, Mimura H, Kanazawa S (2007) Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 134:1306–1312PubMedCrossRef

14.

Pennathur A, Luketich JD, Abbas G, Chen M, Fernando HC, Gooding WE, Schuchert MJ, Gilbert S, Christie NA, Landreneau RJ (2007) Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 134:857–864PubMedCrossRef

15.

Hoffmann RT, Jakobs TF, Kubisch CH, Trumm CG, Weber C, Duerr HR, Helmberger TK, Reiser MF (2010) Radiofrequency ablation in the treatment of osteoid osteoma-5-year experience. Eur J Radiol 73:374–379PubMedCrossRef

16.

Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ (2003) Osteoid osteoma: percutaneous treatment with radiofrequency energy. Radiology 229:171–175PubMedCrossRef

17.

Zlotta AR, Wildschutz T, Raviv G, Peny MO, van Gansbeke D, Noel JC, Schulman CC (1997) Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol Endourol Soc 11:251–258CrossRef

18.

Lau WY, Leung TW, Yu SC, Ho SK (2003) Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 237:171–179PubMedCentralPubMed

19.

Wah T, Irving H, Gregory W, Cartledge J, Joyce A, Selby P (2014) Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int 113(3):416–428. doi:10.1111/bju.12349

20.

Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, Faraday MM, Kaouk JH, Leveillee RJ, Matin SF, Russo P, Uzzo RG (2009) Guideline for management of the clinical T1 renal mass. J Urol 182:1271–1279PubMedCrossRef

21.

Kunkle DA, Uzzo RG (2008) Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 113:2671–2680PubMedCentralPubMedCrossRef

22.

Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA (2012) Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 61:1156–1161PubMedCrossRef

23.

Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G (2009) Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol 182:2158–2163PubMedCentralPubMedCrossRef

24.

Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, Tanguay S, Rendon RA, Gleave ME, Drachenberg DE, Chow R, Chung H, Chin JL, Fleshner NE, Evans AJ, Gallie BL, Haider MA, Kachura JR, Kurban G, Fernandes K, Finelli A (2011) Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 60:39–44PubMedCrossRef

25.

Kroeger N, Choueiri TK, Lee JL, Bjarnason GA, Knox JJ, Mackenzie MJ, Wood L, Srinivas S, Vaishamayan UN, Rha SY, Pal SK, Yuasa T, Donskov F, Agarwal N, Tan MH, Bamias A, Kollmannsberger CK, North SA, Rini BI, Heng DY (2013) Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy. Eur Urol. doi:10.1016/j.eururo.2013.07.031

26.

Skinner EC, Goldman B, Sakr WA, Petrylak DP, Lenz HJ, Lee CT, Wilson SS, Benson M, Lerner SP, Tangen CM, Thompson IM (2013) SWOG S0353: phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guerin. J Urol 190:1200–1204PubMedCrossRef

27.

Klatte T, Mauermann J, Heinz-Peer G, Waldert M, Weibl P, Klingler HC, Remzi M (2011) Perioperative, oncologic, and functional outcomes of laparoscopic renal cryoablation and open partial nephrectomy: a matched pair analysis. J Endourol 25:991–997PubMedCrossRef

28.

Tanagho YS, Roytman TM, Bhayani SB, Kim EH, Benway BM, Gardner MW, Figenshau RS (2012) Laparoscopic cryoablation of renal masses: single-center long-term experience. Urology 80:307–314PubMedCrossRef

29.

Aron M, Kamoi K, Remer E, Berger A, Desai M, Gill I (2010) Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol 183:889–895PubMedCrossRef

30.

Beemster PW, Barwari K, Mamoulakis C, Wijkstra H, de la Rosette JJ, Laguna MP (2011) Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results. BJU Int 108:577–582PubMedCrossRef

31.

Guazzoni G, Cestari A, Buffi N, Lughezzani G, Nava L, Cardone G, Balconi G, Lazzeri M, Montorsi F, Rigatti P (2010) Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors: 8 years of experience in a single institution. Urology 76:624–629PubMedCrossRef

32.

Laguna MP, Beemster P, Kumar V, Klingler HC, Wyler S, Anderson C, Keeley FX, Bachmann A, Rioja J, Mamoulakis C, Marberger M, de la Rosette JJ (2009) Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. Eur Urol 56:355–361PubMedCrossRef

33.

Klatte T, Grubmüller B, Waldert M, Weibl P, Remzi M (2011) Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol 60:435–443PubMedCrossRef

34.

Klatte T, Shariat SF, Remzi M (2013) Systematic review and meta-analysis of perioperative and oncological outcomes of laparoscopic cryoablation versus laparoscopic partial nephrectomy for the treatment of small renal tumors. J Urol. doi:10.1016/j.juro.2013.1011.1006

35.

Emara AM, Kommu SS, Hindley RG, Barber NJ (2014) Robot-assisted partial nephrectomy vs laparoscopic cryoablation for the small renal mass: redefining the minimally invasive ‘gold standard’. BJU Int 113:92–99PubMedCrossRef

36.

Atwell TD, Callstrom MR, Farrell MA, Schmit GD, Woodrum DA, Leibovich BC, Chow GK, Patterson DE, Blute ML, Charboneau JW (2010) Percutaneous renal cryoablation: local control at mean 26 months of followup. J Urol 184:1291–1295PubMedCrossRef

37.

Kim EH, Tanagho YS, Bhayani SB, Saad NE, Benway BM, Figenshau RS (2013) Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours. BJU Int 111:872–879PubMedCrossRef

38.

Sisul DM, Liss MA, Palazzi KL, Briles K, Mehrazin R, Gold RE, Masterson JH, Mirheydar HS, Jabaji R, Stroup SP, L’Esperance JO, Wake RW, Rivera-Sanfeliz G, Derweesh IH (2013) RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis. Urology 81:775–780PubMedCrossRef

39.

Tsivian M, Chen VH, Kim CY, Zilberman DE, Mouraviev V, Nelson RC, Albala DM, Polascik TJ (2010) Complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center. Eur Urol 58:142–147PubMedCrossRef

40.

Buy X, Lang H, Garnon J, Sauleau E, Roy C, Gangi A (2013) Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. AJR Am J Roentgenol 201:1353–1361PubMedCrossRef

41.

Hegg RM, Schmit GD, Boorjian SA, McDonald RJ, Kurup AN, Weisbrod AJ, Callstrom MR, Atwell TD, Thompson RH (2013) Percutaneous renal cryoablation after partial nephrectomy: technical feasibility, complications and outcomes. J Urol 189:1243–1248PubMedCrossRef

42.

Finley DS, Beck S, Box G, Chu W, Deane L, Vajgrt DJ, McDougall EM, Clayman RV (2008) Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 180:492–498 (discussion 498)

43.

Strom KH, Derweesh I, Stroup SP, Malcolm JB, L’Esperance J, Wake RW, Gold R, Fabrizio M, Palazzi-Churas K, Gu X, Wong C (2011) Second prize: recurrence rates after percutaneous and laparoscopic renal cryoablation of small renal masses: does the approach make a difference? J Endourol 25:371–375PubMedCrossRef

44.

Malcolm JB, Berry TT, Williams MB, Logan JE, Given RW, Lance RS, Barone B, Shaves S, Vingan H, Fabrizio MD (2009) Single center experience with percutaneous and laparoscopic cryoablation of small renal masses. J Endourol 23:907–911PubMedCrossRef

45.

Badwan K, Maxwell K, Venkatesh R, Figenshau RS, Brown D, Chen C, Bhayani SB (2008) Comparison of laparoscopic and percutaneous cryoablation of renal tumors: a cost analysis. J Endourol 22:1275–1277PubMedCrossRef

46.

Panumatrassamee K, Kaouk JH, Autorino R, Lenis AT, Laydner H, Isac W, Long JA, Eyraud R, Kassab A, Khalifeh A, Hillyer S, Rizkala E, Haber GP, Stein RJ (2013) Cryoablation versus minimally invasive partial nephrectomy for small renal masses in the solitary kidney: impact of approach on functional outcomes. J Urol 189:818–822PubMedCrossRef

47.

Klatte T, Marberger M (2009) High-intensity focused ultrasound for the treatment of renal masses: current status and future potential. Curr Opin Urol 19:188–191PubMedCrossRef

48.

Wu F (2006) Extracorporeal high intensity focused ultrasound in the treatment of patients with solid malignancy. Minim Invasive Ther Allied Technol Off J Soc Minim Invasive Ther 15:26–35CrossRef

49.

Häcker A, Michel MS, Marlinghaus E, Köhrmann KU, Alken P (2006) Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound. BJU Int 97:779–785PubMedCrossRef

50.

Marberger M, Schatzl G, Cranston D, Kennedy JE (2005) Extracorporeal ablation of renal tumours with high-intensity focused ultrasound. BJU Int 95(Suppl 2):52–55PubMedCrossRef

51.

Illing RO, Kennedy JE, Wu F, ter Haar GR, Protheroe AS, Friend PJ, Gleeson FV, Cranston DW, Phillips RR, Middleton MR (2005) The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer 93:890–895PubMedCentralPubMedCrossRef

52.

Ritchie RW, Leslie T, Phillips R, Wu F, Illing R, ter Haar G, Protheroe A, Cranston D (2010) Extracorporeal high intensity focused ultrasound for renal tumours: a 3-year follow-up. BJU Int 106:1004–1009PubMedCrossRef

53.

Orvieto MA, Zorn KC, Lyon MB, Tolhurst SR, Rapp DE, Seip R, Sanghvi N, Shalhav A (2009) High intensity focused ultrasound renal tissue ablation: a laparoscopic porcine model. J Urol 181:861–866PubMedCrossRef

54.

Paterson RF, Barret E, Siqueira TM Jr, Gardner TA, Tavakkoli J, Rao VV, Sanghvi NT, Cheng L, Shalhav AL (2003) Laparoscopic partial kidney ablation with high intensity focused ultrasound. J Urol 169:347–351PubMedCrossRef

55.

Klingler HC, Susani M, Seip R, Mauermann J, Sanghvi N, Marberger MJ (2008) A novel approach to energy ablative therapy of small renal tumours: laparoscopic high-intensity focused ultrasound. Eur Urol 53:810–816 (discussion 817–818)

56.

Ritchie RW, Leslie TA, Turner GD, Roberts IS, D’Urso L, Collura D, Demarchi A, Muto G, Sullivan ME (2011) Laparoscopic high-intensity focused ultrasound for renal tumours: a proof of concept study. BJU Int 107:1290–1296PubMedCrossRef

57.

Desai MM, Aron M, Gill IS (2005) Laparoscopic partial nephrectomy versus laparoscopic cryoablation for the small renal tumor. Urology 66:23–28PubMedCrossRef

58.

Haber GP, Lee MC, Crouzet S, Kamoi K, Gill IS (2012) Tumour in solitary kidney: laparoscopic partial nephrectomy vs laparoscopic cryoablation. BJU Int 109:118–124PubMedCrossRef

59.

Haramis G, Graversen JA, Mues AC, Korets R, Rosales JC, Okhunov Z, Badani KK, Gupta M, Landman J (2012) Retrospective comparison of laparoscopic partial nephrectomy versus laparoscopic renal cryoablation for small (<3.5 cm) cortical renal masses. J Laparoendosc Adv Surg Tech Part A 22:152–157CrossRef

60.

Hruby G, Reisiger K, Venkatesh R, Yan Y, Landman J (2006) Comparison of laparoscopic partial nephrectomy and laparoscopic cryoablation for renal hilar tumors. Urology 67:50–54PubMedCrossRef

61.

Lin YC, Turna B, Frota R, Aron M, Haber GP, Kamoi K, Koenig P, Gill IS (2008) Laparoscopic partial nephrectomy versus laparoscopic cryoablation for multiple ipsilateral renal tumors. Eur Urol 53:1210–1216PubMedCrossRef

62.

Lughezzani G, Cestari A, Buffi NM, Scapaticci E, Fabbri F, Sangalli M, Nava L, Montorsi M, Rigatti P, Guazzoni G (2009) Nephron sparing surgery for the treatment of small renal masses: comparison between open partial nephrectomy, laparoscopic partial nephrectomy and laparoscopic cryoablation. Eur Urol Suppl 8:126CrossRef

63.

Nisbet AA, Rieder JM, Tran VQ, Williams SG, Chien GW (2009) Decision tree for laparoscopic partial nephrectomy versus laparoscopic renal cryoablation for small renal masses. J Endourol Endourol Soc 23:431–437CrossRef

64.

O’Malley RL, Berger AD, Kanofsky JA, Phillips CK, Stifelman M, Taneja SS (2007) A matched-cohort comparison of laparoscopic cryoablation and laparoscopic partial nephrectomy for treating renal masses. BJU Int 99:395–398PubMedCrossRef

65.

Turna B, Kaouk JH, Frota R, Stein RJ, Kamoi K, Gill IS, Novick AC (2009) Minimally invasive nephron sparing management for renal tumors in solitary kidneys. J Urol 182:2150–2157PubMedCrossRef

66.

Guillotreau J, Haber GP, Autorino R, Miocinovic R, Hillyer S, Hernandez A, Laydner H, Yakoubi R, Isac W, Long JA, Stein RJ, Kaouk JH (2012) Robotic partial nephrectomy versus laparoscopic cryoablation for the small renal mass. Eur Urol 61:899–904PubMedCrossRef

Titel: The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation
verfasst von: Tobias Klatte
Nils Kroeger
Uwe Zimmermann
Martin Burchardt
Arie S. Belldegrun
Allan J. Pantuck
Publikationsdatum: 01.06.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 3/2014
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-014-1284-7

Neu im Fachgebiet Urologie

25.04.2024 | Nierenkarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation

Abstract

Introduction

Objective

Methods

Results

Conclusion

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie

Springer Medizin

Abstract

Introduction

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

The Integral Theory System Questionnaire: an anatomically directed questionnaire to determine pelvic floor dysfunctions in women

Hereditary renal cell carcinoma: genetics, clinical features, and surgical considerations

Selective angioembolization for traumatic renal injuries: a survey on clinician practice

Surgical management of metastatic renal cell carcinoma in the era of targeted therapies

The contemporary role on surgery in the management of renal masses

The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie